Seth Bechis

TitleAssociate Physician
InstitutionUniversity of California San Diego
Address9300 Campus Point Drive #7897
La Jolla CA 92037
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Massachusetts General Hospital, Boston, MAResidencyUrology Residency
    UC San Diego, San Diego, CAFellowshipFellowship in Endourology and Robotic Surgery
    University of California, San Francisco, San Francisco, CAM.S.Biomedical Sciences
    University of California, San Francisco, San Francisco, CAM.D.Medicine
    Harvard University, Cambridge, MAA.B.Chemistry

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bechis S, Han DS, Abbott JE, Holst DD, Alagh A, DiPina T, Sur RL. Outpatient Percutaneous Nephrolithotomy: The UC San Diego Health Experience. J Endourol. 2018 May; 32(5):394-401. PMID: 29634376.
      View in: PubMed
    2. Papagiannopoulos D, Holst D, Bechis S, Sur RL. A Homeopathic Alternative to Potassium Citrate in Patients with Recurrent Nephrolithiasis. Urology. 2018 Mar 06. PMID: 29522867.
      View in: PubMed
    3. Bechis S, Abbott JE, Sur RL. In vitro head-to-head comparison of the durability, versatility and efficacy of the NGage and novel Dakota stone retrieval baskets. Transl Androl Urol. 2017 Dec; 6(6):1144-1149. PMID: 29354502.
      View in: PubMed
    4. Wang Z, Hu L, Salari K, Bechis S, Ge R, Wu S, Rassoulian C, Pham J, Wu CL, Tabatabaei S, Strand DW, Olumi AF. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5a-reductase 2. J Pathol. 2017 12; 243(4):457-467. PMID: 28940538.
      View in: PubMed
    5. Grant MT, Eisner BH, Bechis S. Ureteral Obstruction Due to Radiolucent Atazanavir Ureteral Stones. J Endourol Case Rep. 2017; 3(1):152-154. PMID: 29098200.
      View in: PubMed
    6. Wintner A, Kim MM, Bechis S, Kreydin EI. Voiding Dysfunction in Multiple Sclerosis. Semin Neurol. 2016 Apr; 36(2):219-20. PMID: 27116728.
      View in: PubMed
    7. Wintner A, Kim MM, Bechis S, Kreydin EI. Voiding Dysfunction in Multiple Sclerosis. Semin Neurol. 2016 Feb; 36(1):34-40. PMID: 26866494.
      View in: PubMed
    8. Sanchez A, Rodríguez D, Allard CB, Bechis S, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW, Preston MA, Feldman AS. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort. Urol Oncol. 2016 Apr; 34(4):166.e7-14. PMID: 26739672.
      View in: PubMed
    9. Bechis S, Otsetov AG, Ge R, Wang Z, Vangel MG, Wu CL, Tabatabaei S, Olumi AF. Age and Obesity Promote Methylation and Suppression of 5a-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia. J Urol. 2015 Oct; 194(4):1031-7. PMID: 25916673; PMCID: PMC4761873.
    10. Ge R, Wang Z, Bechis S, Otsetov AG, Hua S, Wu S, Wu CL, Tabatabaei S, Olumi AF. DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate. Am J Pathol. 2015 Mar; 185(3):870-82. PMID: 25700986; PMCID: PMC4348471.
    11. Bechis S, Eisner BH. Editorial comment. Urology. 2014 Sep; 84(3):542-3. PMID: 25168530.
      View in: PubMed
    12. Bechis S, Eisner BH. The STONE score can help diagnose urolithiasis and decrease the use of CT scans. Evid Based Med. 2014 Dec; 19(6):234. PMID: 25053641.
      View in: PubMed
    13. Bechis S, Otsetov AG, Ge R, Olumi AF. Personalized medicine for the management of benign prostatic hyperplasia. J Urol. 2014 Jul; 192(1):16-23. PMID: 24582540; PMCID: PMC4143483.
    14. Costa MJ, Wu X, Cuervo H, Srinivasan R, Bechis S, Cheang E, Marjanovic O, Gridley T, Cvetic CA, Wang RA. Notch4 is required for tumor onset and perfusion. Vasc Cell. 2013 Apr 20; 5(1):7. PMID: 23601498; PMCID: PMC3644271.
    15. Bechis S, Carroll PR, Cooperberg MR. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011 Jan 10; 29(2):235-41. PMID: 21135285; PMCID: PMC3058279.
    16. Eisner BH, Porten SP, Bechis S, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. 2010 Jun; 183(6):2244-8. PMID: 20400141.
      View in: PubMed
    17. Eisner BH, Porten SP, Bechis S, Stoller ML. The role of race in determining 24-hour urine composition in white and Asian/Pacific Islander stone formers. J Urol. 2010 Apr; 183(4):1407-11. PMID: 20171692.
      View in: PubMed
    18. Eisner BH, Porten SP, Bechis S, Stoller ML. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol. 2010 Feb; 183(2):576-9. PMID: 20018328.
      View in: PubMed
    19. Kouros-Mehr H, Kim JW, Bechis S, Werb Z. GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol. 2008 Apr; 20(2):164-70. PMID: 18358709; PMCID: PMC2397451.
    20. Kouros-Mehr H, Bechis S, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell. 2008 Feb; 13(2):141-52. PMID: 18242514; PMCID: PMC2262951.
    21. Wei H, Ruthenburg AJ, Bechis S, Verdine GL. Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase. J Biol Chem. 2005 Nov 04; 280(44):37041-7. PMID: 16100112.
      View in: PubMed